4qkh
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | ''' | + | ==Dimeric form of human LLT1, a ligand for NKR-P1== |
| - | + | <StructureSection load='4qkh' size='340' side='right' caption='[[4qkh]], [[Resolution|resolution]] 1.80Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[4qkh]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4QKH OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4QKH FirstGlance]. <br> | |
| - | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr> | |
| - | + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4qkg|4qkg]], [[4qki|4qki]], [[4qkj|4qkj]]</td></tr> | |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4qkh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qkh OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4qkh RCSB], [http://www.ebi.ac.uk/pdbsum/4qkh PDBsum]</span></td></tr> | |
| - | [[Category: | + | </table> |
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/CLC2D_HUMAN CLC2D_HUMAN]] Receptor for KLRB1 that protects target cells against natural killer cell-mediated lysis. Inhibits osteoclast formation. Inhibits bone resorption. Modulates the release of interferon-gamma. Binds high molecular weight sulfated glycosaminoglycans.<ref>PMID:14753741</ref> <ref>PMID:15104121</ref> <ref>PMID:16339513</ref> | ||
| + | == References == | ||
| + | <references/> | ||
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Blaha, J]] | ||
[[Category: Dohnalek, J]] | [[Category: Dohnalek, J]] | ||
[[Category: Duskova, J]] | [[Category: Duskova, J]] | ||
[[Category: Harlos, K]] | [[Category: Harlos, K]] | ||
| - | [[Category: Stransky, J]] | ||
| - | [[Category: Blaha, J]] | ||
| - | [[Category: Vanek, O]] | ||
[[Category: Hasek, J]] | [[Category: Hasek, J]] | ||
[[Category: Koval, T]] | [[Category: Koval, T]] | ||
[[Category: Skalova, T]] | [[Category: Skalova, T]] | ||
| + | [[Category: Stransky, J]] | ||
| + | [[Category: Vanek, O]] | ||
| + | [[Category: Anchored in membrane on cell surface]] | ||
| + | [[Category: C-type lectin like fold]] | ||
| + | [[Category: Deglycosylated after the first glcnac unit]] | ||
| + | [[Category: Glycosylation]] | ||
| + | [[Category: Immune system]] | ||
| + | [[Category: Ligand for human receptor nkr-p1]] | ||
Revision as of 11:55, 11 March 2015
Dimeric form of human LLT1, a ligand for NKR-P1
| |||||||||||
